Talis Biomedical Corporation
TLIS
$1.60
-$0.08-4.76%
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
--
Headlines
9/19/2024
-
Zolmax
8/20/2024
-
InvestorPlace
8/14/2024
-
Ticker Report
8/7/2024
-
InvestorPlace
8/7/2024
-
InvestorPlace
8/6/2024
-
TipRanks Financial Blog
7/30/2024
-
Globe Newswire
6/30/2024
-
Ticker Report
6/29/2024
-
Zolmax
6/7/2024
-
Ticker Report
5/8/2024
-
InvestorPlace
4/27/2024
-
Globe Newswire
4/11/2024
-
TipRanks Financial Blog
3/29/2024
-
InvestorPlace
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Monday, August 19, 2024
Period Date
Sunday, June 30, 2024
Next Filing
(est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
650 433 3000
Address
1375 West Fulton Market
Chicago, IL 60607
Chicago, IL 60607
Country
Year Founded
Business Description
Sector
Industry
Talis Biomedical Corporation operates as a molecular diagnostic company, focusing on developing medical devices for infectious diseases and other conditions at the point of care in the United...
more
